EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In silico study of the mechanisms of hypoxia and contractile dysfunction during ischemia and reperfusion of hiPSC cardiomyocytes

Mohamadamin Forouzandehmehr iD, Michelangelo Paci iD, Jari Hyttinen iD, Jussi T Koivumäki iD

Disease Models & Mechanisms · 2024

DOI: 10.1242/dmm.050365 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Disease Models & Mechanisms, 2024. Verfasst von Mohamadamin Forouzandehmehr und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Induced Pluripotent Stem Cells, Sarcoplasmic Reticulum Calcium-Transporting ATPases, Computer Simulation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pirkanmaan Rahasto, Suomen Kulttuurirahasto, Tampereen Yliopisto.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interconnected mechanisms of ischemia and reperfusion (IR) has increased the interest in IR in vitro experiments using human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). We developed a whole-cell computational model of hiPSC-CMs including the electromechanics, a metabolite-sensitive sarcoplasmic reticulum Ca2+-ATPase (SERCA) and an oxygen dynamics formulation to investigate IR mechanisms. Moreover, we simulated the effect and action mechanism of levosimendan, which recently showed promising anti-arrhythmic effects in hiPSC-CMs in hypoxia. The model was validated using hiPSC-CM and in vitro animal data. The role of SERCA in causing relaxation dysfunction in IR was anticipated to be comparable to its function in sepsis-induced heart failure. Drug simulations showed that levosimendan counteracts the relaxation dysfunction by utilizing a particular Ca2+-sensitizing mechanism involving Ca2+-bound troponin C and Ca2+ flux to the myofilament, rather than inhibiting SERCA phosphorylation. The model demonstrates extensive characterization and promise for drug development, making it suitable for evaluating IR therapy strategies based on the changing levels of cardiac metabolites, oxygen and molecular pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocytes, CardiacInduced Pluripotent Stem CellsSarcoplasmic Reticulum Calcium-Transporting ATPasesComputer SimulationSimendanMyocardial ContractionCalciumHumansCell HypoxiaOxygenMyocardial Reperfusion InjuryAnimalsModels, Biological

Stichwörter der Autor:innen

In silico modelingAction potentialCardiac metabolismHuman stem cell-derived cardiomyocytesIschemiaLevosimendanPharmacologyReperfusion

Substanzen

Sarcoplasmic Reticulum Calcium-Transporting ATPasesSimendanCalciumOxygen

Autor:innen und Institutionen

  • Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland.
  • Department of Electrical, Electronic, and Information Engineering 'Guglielmo Marconi', University of Bologna, 47522 Cesena, Italy.

ORCID-Profile: Mohamadamin Forouzandehmehr, Michelangelo Paci, Jari Hyttinen, Jussi T Koivumäki

Förderung

  • Pirkanmaan Rahasto
  • Suomen Kulttuurirahasto
  • Tampereen Yliopisto
  • Sydäntutkimussäätiö

Zitieren

APA

Forouzandehmehr, M., Paci, M., Hyttinen, J., & Koivumäki, J. T. (2024). In silico study of the mechanisms of hypoxia and contractile dysfunction during ischemia and reperfusion of hiPSC cardiomyocytes. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.050365

Vancouver

Forouzandehmehr M, Paci M, Hyttinen J, Koivumäki JT. In silico study of the mechanisms of hypoxia and contractile dysfunction during ischemia and reperfusion of hiPSC cardiomyocytes. Disease Models & Mechanisms. 2024. doi:10.1242/dmm.050365

BibTeX
@article{Forouzandehmehr2024,
  author = {Forouzandehmehr, Mohamadamin and Paci, Michelangelo and Hyttinen, Jari and Koivumäki, Jussi T},
  title = {In silico study of the mechanisms of hypoxia and contractile dysfunction during ischemia and reperfusion of hiPSC cardiomyocytes},
  journal = {Disease Models & Mechanisms},
  year = {2024},
  doi = {10.1242/dmm.050365}
}
Kostenlos starten →